Ledger.Open graph →
SEC Form D · filed June 27, 2022

RevOpsis Therapeutics Corp

Offering
$521K
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Springfield, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Ramanath Bhandari · Springfield, ILExec · Director · PromoterSabrina Vallano · London, United KingdomExec · Director · PromoterJeff Olson · Chicago, ILDirectorRam Palanki · Springfield, ILExec · DirectorCarly Brantz · SAN FRANCISCO, CAExec · Director · PromoterJeff Olson · Longmont, CODirectorRam Palanki · Springfield, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗